SCHEMBL17607182

SCHEMBL17607182

CCOc1ncccc1NC(=O)c1ccc[nH]1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
GAA P10253 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 4/20 0.46
POLB P06746 2/20 0.46
TSHR P16473 2/20 0.45
NPC1 O15118 1/20 0.45
MAPT P10636 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
RXFP1 Q9HBX9 3/20 0.45
PPARG P37231 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
KCNMA1 Q12791 1/20 0.43
MEN1 O00255 3/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7850023 0.78 L3MBTL1 (0.56) L3MBTL1GAAKMT2APOLBTSHR
SCHEMBL17607158 0.78 GSK3B (0.51) GAASMN1; SMN2KMT2APOLBTSHR
SCHEMBL26789765 0.76 L3MBTL1 (0.54) L3MBTL1GAAKMT2ATSHRNPC1
SCHEMBL2678200 0.76 KDM4E (0.48) L3MBTL1GAASMN1; SMN2KMT2ATSHR
SCHEMBL17607157 0.73 MAPK7 (0.57) GAA
SCHEMBL7848797 0.72 METAP1 (0.52) L3MBTL1GAAKMT2APOLBTSHR
SCHEMBL15452783 0.72 L3MBTL1 (0.53) L3MBTL1GAASMN1; SMN2KMT2APOLB
SCHEMBL17607192 0.71 KCNMA1 (0.45) POLBLMNAKCNMA1KDM4E
SCHEMBL13506055 0.70 HPGD (0.62) L3MBTL1GAAKMT2APOLBNPC1
SCHEMBL19476139 0.70 KMT2A (0.56) GAASMN1; SMN2KMT2ATSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194390-A1 PYRROLCARBOXAMIDE DERIVATIVES FOR THE INHBITION OF ERK5 Cancer Research Technology Ltd (GB) 2017-07-26 EP claimed
WO-2016042341-A1 PYRROLCARBOXAMIDE DERIVATIVES FOR THE INHBITION OF ERK5 CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-03-24 WO claimed